Mandate

Vinge advises ABG, SEB and Swedbank in connection with a directed share issue in Hemfosa

June 20, 2018

Vinge advises ABG Sundal Collier, Skandinaviska Enskilda Banken and Swedbank who are acting as Joint Lead Managers and Bookrunners in connection with Hemfosa Fastigheter’s directed share issue, on the basis of an authorisation from the annual general meeting, of 10 million common shares, raising proceeds of SEK 1,085 million.

Hemfosa Fastigheter is a Swedish property company focused on community service properties in the Nordic region, with its largest tenants being the Swedish state and municipalities. Hemfosa’s common share has been listed since March 2014 and its preference share since December 2014, both on Nasdaq Stockholm.
 
Vinge’s team consists of Erik Sjöman, Dain Hård Nevonen and Sofie Bjärtun.
 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025